Szeto Cheuk-Chun, Ng Jack Kit-Chung, Fung Winston Wing-Shing, Luk Cathy Choi-Wan, Wang Gang, Chow Kai-Ming, Lai Ka-Bik, Li Philip Kam-Tao, Lai Fernand Mac-Moune
Department of Medicine & Therapeutics, Prince of Wales Hospital, Hong Kong, China.
Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Kidney Med. 2020 Dec 4;3(1):76-82.e1. doi: 10.1016/j.xkme.2020.11.009. eCollection 2021 Jan-Feb.
RATIONALE & OBJECTIVE: Previous studies have suggested that microRNA-21 (miR-21) plays an important role in kidney fibrosis. We examined the relationship between intrarenal miR-21 level and rate of kidney function loss in immunoglobulin A nephropathy (IgAN).
Prospective cohort study.
SETTING & PARTICIPANTS: 40 patients with IgAN and 10 with hypertensive nephrosclerosis as controls.
miR-21 levels in kidney biopsy specimen and urinary sediment, quantified as ratio to the housekeeping gene.
Kidney event-free survival and rate of kidney function decline.
Time-to-event and correlation analysis.
The IgAN group had significantly higher intrarenal miR-21 expression compared with the hypertensive nephrosclerosis group (1.71 [IQR, 0.99-2.77] vs 0.31 [IQR, 0.25-1.32]; < 0.0001), but urinary miR-21 levels were similar. Intrarenal miR-21 expression had significant but modest correlation with severity of glomerulosclerosis ( = 0.293; = 0.05) and tubulointerstitial fibrosis ( = 0.341; = 0.03). Patients with high intrarenal miR-21 expression had significantly higher risk for developing kidney end points compared with those with low expression (log-rank test, = 0.017). Univariate Cox analysis showed that intrarenal miR-21 expression significantly predicted the development of kidney end points (unadjusted HR, 1.586; 95% CI, 1.179-2.134; = 0.002). However, the result was just short of statistical significance after adjusting for the severity of histologic damage ( = 0.06). There was also a significant correlation between intrarenal miR-21 expression and the slope of kidney function decline by univariate analysis ( = -0.399; = 0.02).
Small sample size; uncertain cellular origin of miR-21.
We found that intrarenal miR-21 expression is increased in patients with IgAN, modestly correlated with the severity of histologic damage, and predictive of subsequent kidney function loss.
既往研究表明,微小RNA-21(miR-21)在肾纤维化中起重要作用。我们研究了免疫球蛋白A肾病(IgAN)患者肾内miR-21水平与肾功能丧失率之间的关系。
前瞻性队列研究。
40例IgAN患者和10例高血压性肾硬化患者作为对照。
肾活检标本和尿沉渣中miR-21水平,以与管家基因的比值进行定量。
无肾脏事件生存期和肾功能下降率。
事件发生时间分析和相关性分析。
与高血压性肾硬化组相比,IgAN组肾内miR-21表达显著更高(1.71[四分位间距,0.99 - 2.77]对0.31[四分位间距,0.25 - 1.32];P < 0.0001),但尿miR-21水平相似。肾内miR-21表达与肾小球硬化严重程度(r = 0.293;P = 0.05)和肾小管间质纤维化(r = 0.341;P = 0.03)显著但中度相关。肾内miR-21高表达患者发生肾脏终点事件的风险显著高于低表达患者(对数秩检验,P = 0.017)。单因素Cox分析显示,肾内miR-21表达显著预测肾脏终点事件的发生(未调整的风险比,1.586;95%置信区间,1.179 - 2.134;P = 0.002)。然而,在调整组织学损伤严重程度后,结果仅接近统计学显著性(P = 0.06)。单因素分析还显示肾内miR-21表达与肾功能下降斜率显著相关(r = -0.399;P = 0.02)。
样本量小;miR-21的细胞来源不确定。
我们发现IgAN患者肾内miR-21表达增加,与组织学损伤严重程度中度相关,并可预测随后的肾功能丧失。